SCHEMBL16401320

SCHEMBL16401320

O=P(c1ccccc1)(c1ccccc1)c1nc2ccccc2cc1O.[LiH]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.46
▸ ALDH1A1 P00352 4/20 0.46
▸ GAA P10253 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ STAT3 P40763 1/20 0.46
▸ MAPT P10636 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ MMP14 P50281 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ GLA P06280 2/20 0.40
▸ ACHE P22303 1/20 0.39
▸ MGAM O43451 2/20 0.39
▸ POLB P06746 2/20 0.37
▸ APOBEC3A P31941 1/20 0.37
▸ CASP6 P55212 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16401011 0.98 KDM4E (0.47) KDM4EALDH1A1GAAHPGDSTAT3
Lithium Ion SCHEMBL16401318 0.77 ALDH1A1 (0.39) KDM4EALDH1A1GAAHPGDMAPT
SCHEMBL11280043 0.77 MAPT (0.43) KDM4EALDH1A1GAAHPGDMAPT
SCHEMBL22837219 0.75 TLR8 (0.37) KDM4EALDH1A1GAAHPGDSTAT3
SCHEMBL11275569 0.69 NPSR1 (0.44) KDM4EALDH1A1GAAHPGDMAPT
SCHEMBL16990165 0.69 ALDH1A1 (0.61) KDM4EALDH1A1GAAHPGDSTAT3
SCHEMBL21503919 0.68 KDR (0.50) KDM4EALDH1A1MAPTLMNAMGAM
SCHEMBL16274573 0.68 EGLN2 (0.41) KDM4EALDH1A1KMT2ALMNAL3MBTL1
SCHEMBL667881 0.67 ALDH1A1 (0.59) KDM4EALDH1A1GAAHPGDSTAT3
SCHEMBL60874 0.67 ALDH1A1 (0.61) KDM4EALDH1A1GAAHPGDSTAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10879473-B2 Organic electronic device NOVALED GMBH (DE) 2020-12-29 — — US disclosed
US-20160118603-A1 Organic Electronic Device NOVALED GMBH (DE) 2016-04-28 — — US disclosed
WO-2014195482-A2 ORGANIC ELECTRONIC DEVICE NOVALED GMBH (DE) 2014-12-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10879473-B2 Organic electronic device OR10J3, LAGE3, L1CAM KDM4E 1309/4885ALDH1A1 886/4885GAA 3187/4885
US-20160118603-A1 Organic Electronic Device OR10J3, LAGE3, L1CAM KDM4E 1309/4885ALDH1A1 886/4885GAA 3187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback